K. Van Kolen

发表

I. van der Linden, G. Vauquelin, F. Dautzenberg, 2009, Molecular Pharmacology.

P. Verstreken, W. Mandemakers, B. de Strooper, 2013, Journal of pharmaceutical and biomedical analysis.

Asbjørn Mohr Drewes, Vitoantonio Bevilacqua, Roshan Cools, 2016 .

Amaia M. Arranz, H. Shaban, P. Verstreken, 2015, Journal of Cell Science.

M. Mercken, W. Galpern, H. Kolb, 2020, Journal of Alzheimer's disease : JAD.

M. Mercken, H. Kolb, G. Triana-Baltzer, 2021, Alzheimer's & dementia.

M. Mercken, L. Schoofs, L. Temmerman, 2020, BMC molecular and cell biology.

J. Trojanowski, M. Vandermeeren, M. Mercken, 2020, Journal of Alzheimer's disease : JAD.

H. Slegers, K. Van Kolen, 2006, Purinergic Signalling Purinergic Signalling.

Rony Nuydens, Julien Colombelli, Jean-Pierre Timmermans, 2019, Neurobiology of Disease.

M. Vandermeeren, M. Mercken, Rupesh K. Nanjunda, 2018, Journal of Alzheimer's disease : JAD.

J. Neefs, F. Dautzenberg, K. Van Kolen, 2008, Journal of neurochemistry.

M. Mercken, L. Schoofs, L. Temmerman, 2020, BMC molecular and cell biology.

Martin H. Koldijk, S. Steinbacher, I. Wilson, 2018, Acta neuropathologica communications.

I. van der Linden, G. Vauquelin, F. Dautzenberg, 2009, Molecular Pharmacology.

K. Van Kolen, Bianca Van Broeck, M. Mercken, 2023, Molecular therapy. Methods & clinical development.